Top-tier venture capital firm specializing in longevity and combating aging diseases.
Location
Las Vegas, NV, US
Founded
2016
Thynk Capital is a top-tier venture capital firm specializing in early-stage investments in Therapeutics, Healthcare, and Technology sectors. The firm focuses on companies dedicated to longevity and combating aging diseases, providing capital and critical value-added resources to optimize performance and increase enterprise value. Thynk Capital typically invests in Convertible Note, Seed, and Series A rounds, aiming to deliver above-market returns to its limited partners.
Notable portfolio companies include Elevian, Klotho Therapeutics, and Repair Biotechnologies. Thynk Capital's investment philosophy emphasizes collaboration with portfolio companies to enhance operational efficiencies, empower management teams, and build strategic roadmaps for sustainable growth and impact. This hands-on approach ensures that their investments not only thrive financially but also contribute significantly to advancements in healthcare and technology.
Thynk Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
